How did this blood cancer medicine get so cheap while it's still under patient — and will generics companies be this lucky again? | via Bhekisisa_MG
”, and is a way for developers to keep on earning profits from old innovations without further benefits to patients.
, an officer who’s at the Companies & Intellectual Property Commission in the department of trade, industry & competition . the only way This kind of system is supposed to shift the responsibility of regulating innovations onto pharmaceutical companies instead of the government. In a perfect world, such a system would give generic drug manufacturers an incentive to take originator companies to court to argue that they’ve won an unfair monopoly, says Jonathan Berger, an advocate with the Johannesburg Bar.
In a case like this, Berger says, the winning company can also use the courts to block the loser’s ability to ever make a generic version of a drug.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Why South Africa’s Minister of Electricity should listen to André de RuyterWhy South Africa's Minister of Electricity should listen to André de Ruyter
Read more »
DAVID FURLONGER: Ford’s Kay Hart has big plans for South AfricaThe New Zealander will be in charge of about 100 emerging and developed countries outside the major new vehicle markets, including South Africa.
Read more »
South Africa’s coalition chaos – government wants a new plan to make parties work togetherThe national government wants a new framework in place to make coalition governance work for the people.
Read more »
Deal or No Deal South Africa has its first BIG winner - WATCHDeal or No Deal South Africa has delivered its first BIG win as South African Siya N won a life-changing R250 000 in the global game show.
Read more »